Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection

NCT01308424 is registered in ClinicalTrials.gov with Beech Tree Labs, Inc. as lead sponsor.

NCT NCT01308424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01308424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection
Lead sponsor
Beech Tree Labs, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2012
Enrollment
171 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

oral herpes simplex